These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7411408)
1. Topographical model of the renal vascular dopamine receptor. Erhardt PW J Pharm Sci; 1980 Sep; 69(9):1059-61. PubMed ID: 7411408 [TBL] [Abstract][Full Text] [Related]
2. Similarities and differences of dopamine receptors in the renal vascular bed and elsewhere. Goldberg LI; Volkman PH; Kohli JD; Kotake AN Adv Biochem Psychopharmacol; 1977; 16():251-6. PubMed ID: 196488 [No Abstract] [Full Text] [Related]
3. Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors. Kohli JD; Weder AB; Goldberg LI; Ginos JZ J Pharmacol Exp Ther; 1980 May; 213(2):370-4. PubMed ID: 7365696 [No Abstract] [Full Text] [Related]
4. Vascular dopamine receptors: Demonstration and characterization by in vitro studies. Brodde OE Life Sci; 1982 Jul; 31(4):289-306. PubMed ID: 6292644 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of rat kidney dopamine receptors and the effects of renal denervation and dopamine infusion on these receptors. Katayama E; Ogura T; Ota Z Nephron; 1989; 53(4):358-63. PubMed ID: 2601804 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic receptors: a new antihypertensive mechanism. Velasco M; Contreras F; Cabezas GA; Bolívar A; Fouillioux C; Hernández R J Hypertens Suppl; 2002 Jun; 20(3):S55-8. PubMed ID: 12184056 [TBL] [Abstract][Full Text] [Related]
11. Vasodilator effects of dopaminomimetics in the perfused rat kidney. Schmidt M; Imbs JL; Giesen EM; Schwartz J Eur J Pharmacol; 1982 Oct; 84(1-2):61-70. PubMed ID: 6183130 [TBL] [Abstract][Full Text] [Related]
12. Conformational requirements for dopamine-induced vasodilation. Volkman PH; Kohli JD; Goldberg LI; Cannon JG; Lee T Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3602-6. PubMed ID: 269416 [TBL] [Abstract][Full Text] [Related]
13. Characterization of dopamine receptor subtypes by comparative structure-activity relationships: dopaminomimetic activities and solid state conformation of monohydroxy-1,2,3,4,4a,5,10,10a-octahydrobenz[g]quinolines and its implications for a rotamer-based dopamine receptor model. Seiler MP; Markstein R; Walkinshaw MD; Boelsterli JJ Mol Pharmacol; 1989 May; 35(5):643-51. PubMed ID: 2566903 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic receptor-mediated effects in the mesenteric vasculature and renal vasculature of the chronically instrumented newborn piglet. Pearson RJ; Barrington KJ; Jirsch DW; Cheung PY Crit Care Med; 1996 Oct; 24(10):1706-12. PubMed ID: 8874310 [TBL] [Abstract][Full Text] [Related]
15. 4-(Aminoalkyl)-7-hydroxy-2(3H)-indolones, a novel class of potent presynaptic dopamine receptor agonists. Huffman WF; Hall RF; Grant JA; Wilson JW; Hieble JP; Hahn RA J Med Chem; 1983 Jul; 26(7):933-5. PubMed ID: 6306238 [No Abstract] [Full Text] [Related]
16. Localization of dopamine receptors in the rabbit renal artery: a histoautoradiographic study. Alessandrini C; Cavallotti C; De Rossi M; Fruschelli C; Gerli R; Mione MC; Sacchi G; Amenta F Pharmacology; 1984; 29(1):17-23. PubMed ID: 6205406 [TBL] [Abstract][Full Text] [Related]